Naser Elkum
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 10
- Diabetes Management and Research 3
- Co-authors
- Said Dermime (10 shared papers)Taher Al‐Tweigeri (7 shared papers)Asma Tulbah (5 shared papers)Mohamed Abu‐Farha (18 shared papers)Kazem Behbehani (15 shared papers)Hazem Ghebeh (3 shared papers)Jehad Abubaker (15 shared papers)Shamayel Mohammed (2 shared papers)
- Journals
- PLoS ONE (7 papers)Scientific Reports (3 papers)Cardiovascular Diabetology (3 papers)BMC Cancer (3 papers)Lipids in Health and Disease (2 papers)
- Partner nations
- Saudi ArabiaKuwaitQatar
In The Last Decade
Naser Elkum
71 papers receiving 2.6k citations
Naser Elkum's Hit Papers
Peers
Comparison fields: 5 of 146
- Oncology 875
- Immunology 530
- Endocrinology, Diabetes and Metabolism 398
- Cancer Research 269
- Cardiology and Cardiovascular Medicine 377
Countries citing papers authored by Naser Elkum
This map shows the geographic impact of Naser Elkum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naser Elkum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naser Elkum more than expected).
Fields of papers citing papers by Naser Elkum
This network shows the impact of papers produced by Naser Elkum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naser Elkum. The network helps show where Naser Elkum may publish in the future.
Co-authors
The 25 scholars most cited alongside Naser Elkum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic Factors Hit paper breakdown → | 2006 | 504 |
| 2 | 2008 | 171 | |
| 3 | 2007 | 127 | |
| 4 | 2015 | 106 | |
| 5 | 2007 | 88 | |
| 6 | 2013 | 75 | |
| 7 | 2006 | 70 | |
| 8 | 2016 | 69 | |
| 9 | 2014 | 67 | |
| 10 | 2014 | 63 | |
| 11 | 2016 | 62 | |
| 12 | 2009 | 59 | |
| 13 | 2001 | 59 | |
| 14 | 2015 | 56 | |
| 15 | 2013 | 53 | |
| 16 | 2015 | 52 | |
| 17 | 2014 | 51 | |
| 18 | 2016 | 49 | |
| 19 | 2020 | 47 | |
| 20 | 2014 | 46 |
About Naser Elkum
Naser Elkum is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Oncology, Public Health, Environmental and Occupational Health and Genetics, having authored 73 papers that have together received 2.6k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers), Adipose Tissue and Metabolism (6 papers), Lipid metabolism and disorders (5 papers), Diabetes and associated disorders (4 papers), Genetic Associations and Epidemiology (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Diabetes Management and Research (3 papers). The work is most often cited by research in Oncology (875 citations), Immunology (530 citations), Endocrinology, Diabetes and Metabolism (398 citations), Cancer Research (269 citations) and Cardiology and Cardiovascular Medicine (377 citations). Naser Elkum has collaborated with scholars based in Saudi Arabia, Kuwait and Qatar. Frequent co-authors include Said Dermime, Taher Al‐Tweigeri, Asma Tulbah, Mohamed Abu‐Farha, Kazem Behbehani, Hazem Ghebeh, Jehad Abubaker, Shamayel Mohammed, Dahish Ajarim and Preethi Cherian. Their work appears in journals such as PLoS ONE, Scientific Reports, Cardiovascular Diabetology, BMC Cancer and Lipids in Health and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.